Cequent Pharmaceuticals' Series A Round

Cequent Pharmaceuticals raised a round of funding on January 17, 2008.

Cequent is an early-stage biopharmaceutical company developing new clinically compatible therapies based on RNA interference (RNAi). Cequent is focusing its efforts on the pre-clinical development of …

Articles about Cequent Pharmaceuticals' Series A Round: